Physician profile
Shining Sun
NPI 1851521546
$21,528.69
in general payments reported to CMS, 2019-2025
24 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,453 · 2020: $2,073 · 2021: $1,851 · 2022: $4,819 · 2023: $3,992 · 2024: $4,410 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,932 · Travel and Lodging: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,931.50 |
| Travel and Lodging | $1,400.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,220.86 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite Precision |
| Biosense Webster, INC. | $4,695.85 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic, INC. | $4,126.33 | 2021-2025 | Linq II, Micra, Symplicity G3 |
| Boston Scientific Corporation | $3,881.51 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Medical Device Business Services, INC. | $1,071.22 | 2020 | |
| Medtronic Vascular, INC. | $555.72 | 2019-2020 | |
| Biotronik INC. | $331.34 | 2019-2025 | Amvia Edge |
| Shockwave Medical, INC | $233.22 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acutus Medical, INC. | $212.94 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.96 | 2021-2023 | Lifevest |
| Angiodynamics, INC. | $187.08 | 2022 | |
| Abiomed | $173.02 | 2021-2023 | Impella |
| Philips North America LLC | $159.87 | 2019 | |
| Scpharmaceuticals INC. | $122.03 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.27 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $52.35 | 2022 | |
| Terumo Medical Corporation | $50.93 | 2019 | |
| Cardiva Medical, INC. | $49.42 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Kiniksa Pharmaceuticals International, Plc | $29.59 | 2024 | Arcalyst |
| Zoll Respicardia, INC. | $28.12 | 2025 | Remede System |
| Bayer Healthcare Pharmaceuticals INC. | $24.88 | 2022 | |
| Merck Sharp & Dohme LLC | $24.19 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.99 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shining Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.